Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
CHICAGO, Oct. 26, 2017 -- Amlan International, a global leader in feed additives that improve intestinal health, today announced the opening of its Richard M. Jaffee Laboratory for Applied Microbiology located at the company’s Innovation Center in Vernon Hills, Illinois. The investment includes advanced microbiologists, research instruments and equipment dedicated to accelerating Amlan’s technical expertise and new product development.
The Company also announced the hiring of two Senior Research Microbiologists, Dongping Wang, Ph.D. and Shalaka Shinde, Ph.D. The new teammates are experienced microbiologists with specialized expertise and will help advance the company’s efforts in Life Sciences research.
The Biosafety Level 2 lab enables the examination of materials, such as animal feed, intestinal tissue and feces, and their interaction with bacteria or fungus. Pathogen identification, biotoxin diagnosis and bacterial strain enumeration can now be achieved with the lab’s technical and diagnostic capabilities such as the analyses of DNA and RNA proteins (PCR), antimicrobial assays (MIC & MBC), cellular and morphological analyses (Optical Microscopy) and tissue culturing.
Dr. Ron Cravens, President of Amlan International, a Nevada corporation, stated, “We are excited that the new lab will allow us to further our understanding of how our products support intestinal health from within the microbiota. Additionally, we aspire to leverage our expertise and new tools to collaborate with our customers by offering diagnostic testing and technical support. I am confident that the new lab will allow us to optimize our existing product offerings and take product development to new heights.”
The lab was named after Richard M. Jaffee, Chairman of Amlan’s parent company, Oil-Dri Corporation of America. His pioneering spirit and vision for Oil-Dri to conduct research in life sciences has been influential in the development of Amlan’s value-added animal health products. In addition to the previously discussed initiatives, the lab will be used by all facets of Oil-Dri’s business and its development is an investment in the future of the company as a whole.
MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
[email protected]
ABOUT AMLAN INTERNATIONAL
Oil-Dri Corporation of America (NYSE:ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at amlan.com.
